[PLX] YoY Quarter Result on 30-Jun-2011 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
08-Aug-2011
Financial Year
2011
Quarter
30-Jun-2011 [#Q2]
Profit Trend
QoQ- -170.96%
YoY- -36.33%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
Revenue 2,686 3,064 26,113 764 1,141 0 0 -
PBT -6,119 -6,837 22 179 0 0 0 -
Tax 202 0 -8,765 20,699 -109 -446 -669 -
NP -6,119 -6,837 9,642 -13,689 -10,041 -5,427 -4,229 6.34%
Tax Rate - - 39,840.91% -11,563.69% - - - -
Total Cost 8,805 9,901 16,471 14,453 11,182 5,427 4,229 12.99%
Ratio Analysis
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
NP Margin -227.81 -223.14 36.92 -1,791.75 -880.02 0.00 0.00 -
Per Share
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
EPS -0.07 -0.07 0.11 -0.16 -0.12 -0.07 -0.06 2.60%
EPS Diluted -0.07 -0.07 0.10 -0.16 -0.12 -0.07 -0.06 2.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.